FDAnews
www.fdanews.com/articles/175852-boston-scientific-introduces-axios-system
Boston Scientific Logo

Boston Scientific Introduces AXIOS System

March 22, 2016

Boston Scientific has launched its AXIOS stent and electrocautery enhanced delivery system, indicated to manage pancreatic pseudocysts and walled-off pancreatic necrosis.

The lumen-apposing, expandable stent aids in the drainage of pancreatic fluid collections and reduces the risk of leakage and migration, the company says.

AXIOS is the only removable metal stent in the U.S. intended for PFC drainage.

The system lowers costs by minimizing procedural time, length of hospital stay and X-ray exposure. — Anisa Jibrell